Instituto Nacional de Enfermedades Respiratorias
🇲🇽Mexico
Clinical Trials
16
Active:0
Completed:5
Trial Phases
3 Phases
Phase 2:1
Phase 4:1
Not Applicable:10
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
Not Applicable
10 (83.3%)Phase 2
1 (8.3%)Phase 4
1 (8.3%)Glycine and Magnesium+Thiamine for the Treatment of Primary Ciliary Dyskinesia
Not Applicable
Not yet recruiting
- Conditions
- Primary Ciliary Dyskinesia
- First Posted Date
- 2025-05-06
- Last Posted Date
- 2025-05-30
- Lead Sponsor
- Instituto Nacional de Enfermedades Respiratorias
- Target Recruit Count
- 60
- Registration Number
- NCT06959251
- Locations
- 🇲🇽
Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico
Caspofungin for Pneumocystis Pneumonia in PLWHIV.
Recruiting
- Conditions
- HIV-1-infectionPneumocystis Pneumonia
- First Posted Date
- 2024-11-15
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Instituto Nacional de Enfermedades Respiratorias
- Target Recruit Count
- 60
- Registration Number
- NCT06691321
- Locations
- 🇲🇽
Center for Research in Infectious Diseases (CIENI), Mexico City, Tlalpan, Mexico
Applying Artificial Intelligence to Identify Subphenotypes of Acute Kidney Injury in Mexican Patients With Severe COVID-19
Completed
- Conditions
- Acute Kidney InjuryCOVID-19
- First Posted Date
- 2024-06-24
- Last Posted Date
- 2024-06-24
- Lead Sponsor
- Instituto Nacional de Enfermedades Respiratorias
- Target Recruit Count
- 2934
- Registration Number
- NCT06471101
- Locations
- 🇲🇽
Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico
Morphofunctional, Gene, Inflammation Molecules and Oxidative Stress Analysis in Kidney Tissue of COVID-19 Patients
Completed
- Conditions
- COVID-19Inflammatory ResponseKidney InjuryGene AmplificationOxidative Stress
- First Posted Date
- 2024-06-06
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- Instituto Nacional de Enfermedades Respiratorias
- Target Recruit Count
- 40
- Registration Number
- NCT06444893
- Locations
- 🇲🇽
National Institute of Respiratory Diseases, Mexico City, Ciudad DE México, Mexico
Renal Biomarkers in AKI and COVID-19
Completed
- Conditions
- Coronavirus InfectionCovid19AKISARS (Severe Acute Respiratory Syndrome)
- First Posted Date
- 2020-08-18
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- Instituto Nacional de Enfermedades Respiratorias
- Target Recruit Count
- 51
- Registration Number
- NCT04517630
- Locations
- 🇲🇽
Centro de Investigacion en Enfermedades Infecciosas, Mexico City, Mexico
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found